Email Updates

Search form

You are here

HIV Vaccine

There is momentum and promise in the search for an HIV vaccine.

An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital HIV vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

A team of Ugandan researchers will lead a six-year HIV vaccine research in East Africa in an effort to find an HIV vaccine.

May 18, 2018
New Vision

Friday, May 18, marks HIV Vaccine Awareness Day (#HVAD) 2018. Led by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), the observance day gives an opportunity to promote the quest for a preventive vaccine and to thank those involved in the research.

May 18, 2018
POZ

The development of highly effective approaches to HIV treatment and prevention—in the form of combination antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP)—stands among the most impressive scientific achievements in human history.

April 23, 2018
POZ
Subscribe to RSS - HIV Vaccine